18 results
FWP
LGVN
Longeveron Inc - Ordinary Shares
8 Apr 24
Free writing prospectus
8:45am
to patients and creating sustainable value for our shareholders.
Our lead investigational product is Lomecel-B™, which is derived from culture-expanded … .
These priorities underscore our commitment to delivering value to patients and shareholders alike, and to continue our pursuit of sustainable growth
DEF 14A
LGVN
Longeveron Inc - Ordinary Shares
13 May 22
Definitive proxy
4:10pm
Beach. Mr. Rock Soffer is an advocate for responsible, environmentally sustainable development.
Vote Required for Approval and Recommendation of Board
424B3
9jn85hl ire4t6ol5jql
22 Dec 21
Prospectus supplement
5:07pm
10-K
nlwf8ap
30 Mar 21
Annual report
4:51pm
424B4
ei62n
12 Feb 21
Prospectus supplement with pricing info
4:09pm
S-1
EX-10.5
kpk ojpso5nwdn
19 Jan 21
IPO registration
5:21pm
S-1
w19uhmg738zkb
19 Jan 21
IPO registration
5:21pm
DRS/A
6yll8hybur
30 Dec 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.5
cg9tora84fesb
30 Dec 20
Draft registration statement (amended)
12:00am
DRS
s9rokj3rde64x6ar
12 Nov 20
Draft registration statement
12:00am
- Prev
- 1
- Next